Does INSULIN GLARGINE Cause Lung neoplasm malignant? 92 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 92 reports of Lung neoplasm malignant have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.1% of all adverse event reports for INSULIN GLARGINE.
92
Reports of Lung neoplasm malignant with INSULIN GLARGINE
0.1%
of all INSULIN GLARGINE reports
14
Deaths
27
Hospitalizations
How Dangerous Is Lung neoplasm malignant From INSULIN GLARGINE?
Of the 92 reports, 14 (15.2%) resulted in death, 27 (29.3%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 92 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Off label use (6,842)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which INSULIN GLARGINE Alternatives Have Lower Lung neoplasm malignant Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO